MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 22, 2004; DOI: 10.1124/mol.104.007187


0026-895X/05/6704-1034-1044$20.00
Mol Pharmacol 67:1034-1044, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.104.007187v1
67/4/1034    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagdáany, M.
Right arrow Articles by Panyi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagdáany, M.
Right arrow Articles by Panyi, G.
Original Article

Anuroctoxin, a New Scorpion Toxin of the {alpha}-KTx 6 Subfamily, Is Highly Selective for Kv1.3 over IKCa1 Ion Channels of Human T Lymphocytes

Miklós Bagdáany, Cesar V. F. Batista, Norma A. Valdez-Cruz, Sándor Somodi, Ricardo C. Rodriguez de la Vega, Alexei F. Licea, Zoltáan Varga, Rezso Gáspár, Lourival D. Possani, and György Panyi

Department of Biophysics and Cell Biology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary (M.B., S.S., Z.V., R.G., G.P); Department of Molecular Medicine and Bioprocesses, Institute of Biotechnology, National Autonomous University of Mexico, Avenida Universidad, Cuernavaca, Mexico (C.V.F.B., N.A.V.-C., R.C.R.-V., L.D.P.); and Laboratory of Molecular Immunology and Biotoxins, Centro de Investigación Científica y de Educación de Ensenada, Ensenada, Mexico (A.F.L.)

Abstract

The physiological function of T lymphocytes can be modulated selectively by peptide toxins acting on Kv1.3 K+ channels. Because Kv1.3-specific peptide toxins are considered to have a significant therapeutic potential in the treatment of autoimmune diseases, the discovery of new toxins is highly motivated. Through chromatographic procedures and electrophysiological assays, using patch-clamp methodology, the isolation of a novel peptide named anuroctoxin was accomplished using the venom of the Mexican scorpion Anuroctonus phaiodactylus. It has 35 amino acid residues with a molecular weight of 4082.8, tightly bound by four disulfide bridges whose complete covalent structure was determined. It has a pyroglutamic acid at the N-terminal region and an amidated C-terminal residue. Sequence comparison and phylogenetic clustering analysis classifies anuroctoxin into subfamily 6 of the {alpha}-KTx scorpion toxins (systematic name, {alpha}-KTx 6.12). Patch-clamp experiments show that anuroctoxin is a high-affinity blocker of Kv1.3 channels of human T lymphocytes with a Kd of 0.73 nM, and it does not block the Ca2+-activated IKCa1 K+ channels. These two channels play different but important roles in T-lymphocyte activation. Furthermore, the toxin practically does not inhibit Shaker IR, mKv1.1, and rKv2.1 channels, whereas the affinity of anuroctoxin for hKv1.2 is almost an order of magnitude smaller than for Kv1.3. The pharmacological profile and the selectivity of this new toxin for Kv1.3 over IKCa1 may provide an important tool for the modulation of the immune system, especially in cases in which selective inhibition of Kv1.3 is required.


Received September 15, 2004; accepted December 21, 2004

Address correspondence to: Dr. György Panyi, Department of Biophysics and Cell Biology, University of Debrecen, Medical and Health Science Center, 98 Nagyerdei krt., Debrecen, Hungary 4012. E-mail: panyi{at}jaguar.dote.hu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Beeton, M. W. Pennington, H. Wulff, S. Singh, D. Nugent, G. Crossley, I. Khaytin, P. A. Calabresi, C.-Y. Chen, G. A. Gutman, et al.
Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases
Mol. Pharmacol., April 1, 2005; 67(4): 1369 - 1381.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics